Table 2.
Pharmacological therapy at baseline and after 6 months in the 2 patient groups.
| Exercise group | Control group | Differences in changes between groups | |||
|---|---|---|---|---|---|
| n = 25 | n = 25 | ||||
| Baseline | 6 months | Baseline | 6 months | P value | |
| Fosinopril | 12.2 (3.8) | 11.8 (3.9) | 11.9 (4.1) | 12.5 (5.0) | .732 |
| (mg/d) [n] | [17] | [17] | [16] | [16] | |
| Benazepril | 8.3 (2.3) | 7.8 (2.2) | 8.4 (2.4) | 9.0 (2.3) | .819 |
| (mg/d) [n] | [6] | [6] | [7] | [7] | |
| Bisoprolol | 3.8 (1.5) | 3.4 (1.6) | 4.0 (1.3) | 4.3 (1.5) | .328 |
| (mg/d) [n] | [14] | [14] | [5] | [5] | |
| Nitrendipine | 13.6 (4.3) | 14.1 (4.1) | 14.0 (3.9) | 13.5 (4.2) | .136 |
| (mg/d) [n] | [10] | [10] | [10] | [10] | |
| Felodipine | 6.9 (2.4) | 6.9 (2.4) | 7.1 (2.2) | 7.1 (2.2) | 1 |
| (mg/d) [n] | [9] | [9] | [9] | [9] | |
| Hydrochlorothiazide | 42.6 (9.5) | 41.9 (8.8) | 42.5 (9.4) | 42.5 (9.4) | .739 |
| (mg/d) [n] | [7] | [7] | [7] | [7] | |
| Aspirin | 100 | 100 | 100 | 100 | 1 |
| (mg/d) [n] | [25] | [25] | [25] | [25] | |
Values in parenthesis refer to total daily dosage; (n) refers to the number of patients consuming the drug.